Trials / Completed
CompletedNCT01139593
A Trial Comparing Qam With Qpm Dosing in Assisted Reproductive Technologies (ART)
A Prospective Randomized Trial Comparing Qam With Qpm Daily Dosing in Assisted Reproductive Technologies
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 128 (actual)
- Sponsor
- Virginia Center for Reproductive Medicine · Academic / Other
- Sex
- Female
- Age
- 21 Years – 42 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective randomized trial comparing the outcome in women undergoing IVF/ICSI when taking their gonadotropin dosage in the morning (am) or evening (pm).
Conditions
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2015-11-01
- Completion
- 2015-12-01
- First posted
- 2010-06-08
- Last updated
- 2015-12-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01139593. Inclusion in this directory is not an endorsement.